MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

03 Feb 2024 Evaluate
The sales slipped to Rs. 3.28 millions for the December 2023 quarter as against Rs. 4.27 millions during the year-ago period.The Total Profit for the quarter ended December 2023 of Rs. 1.29 millions grew from Rs.-0.23 millionsThe company reported a good operating profit of 3.19 millions compared to 2.73 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 3.28 4.27 -23.19 4.80 7.03 -31.72 10.19 3.65 179.18
Other Income 5.25 4.45 17.98 15.09 13.18 14.49 17.51 19.19 -8.75
PBIDT 3.19 2.73 16.85 8.14 7.89 3.17 10.60 10.25 3.41
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 3.19 2.73 16.85 8.14 7.89 3.17 10.60 10.25 3.41
Depreciation 0.24 0.24 0.00 0.72 0.70 2.86 0.94 0.92 2.17
PBT 2.95 2.49 18.47 7.42 7.19 3.20 9.66 9.33 3.54
TAX 1.66 2.72 -38.97 3.62 4.12 -12.14 4.63 4.57 1.31
Deferred Tax 0.76 1.72 -55.81 1.46 2.12 -31.13 2.12 0.22 863.64
PAT 1.29 -0.23 -660.87 3.80 3.07 23.78 5.03 4.76 5.67
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 97.26 63.93 52.12 169.58 112.23 51.10 104.02 280.82 -62.96
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..